The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1519
OTC Fluticasone Furoate Nasal Spray (Flonase Sensimist) for Allergic Rhinitis (online only)
The full article is available to subscribers Subscriber Login   

The nasal spray formulation of the corticosteroid fluticasone furoate is now available over the counter (OTC) as Flonase Sensimist Allergy Relief (GSK) in the same strength as the prescription product (Veramyst) for treatment of seasonal or perennial allergic rhinitis. It is the fourth intranasal corticosteroid to become available OTC.

EFFICACY — Intranasal corticosteroids are the most effective drugs available for prevention and relief of seasonal allergic rhinitis symptoms, including itching, sneezing, discharge, and congestion. They are also modestly effective in reducing ocular symptoms.1 The onset of action of intranasal corticosteroids typically occurs within 12 hours, but maximal effects may not be achieved for 7-14 days.

SAFETY — Intranasal corticosteroids can cause dryness, irritation, burning, and bleeding of the nasal ... more       Show References Hide References

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this article:
Title: OTC Fluticasone Furoate Nasal Spray (Flonase Sensimist) for Allergic Rhinitis (online only)
Article code: 1519g
 Electronic, downloadable article - $25